ReviewCHEST pulmonary2023
Mobile Health for Asthma.
Review in CHEST pulmonary, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Digital, remotely delivered management interventions for adult asthma: a systematic review and meta-analysis.Frontiers in public health · 2026Pooled it
- Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Tele-Monitoring Applications in Respiratory Allergy.Journal of clinical medicine · 2024Review
- Medication adherence in allergic diseases and asthma: a literature review.Frontiers in pharmacology · 2024Review
- Exploring the Perspectives and Experiences of Older Adults With Asthma and Chronic Obstructive Pulmonary Disease Toward Mobile Health: Qualitative Study.Journal of medical Internet research · 2023Article
- A text-based conversational agent for asthma support: Mixed-methods feasibility study.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma is a highly prevalent disease associated with significant individual and health system-level burdens. Mobile health (mHealth) apps and connected mobile digital devices, all of which are in the category of mHealth, may have the potential to address many of the important care gaps in asthma. In this narrative review, we document the current state of asthma mHealth for adults, discuss the main challenges to widespread asthma mHealth adoption, and explore future possibilities for asthma mHealth. The number of asthma mHealth options is growing, classified into four discrete categories based on technology type: standalone apps, digital inhalers, digital spirometers, and other mHealth devices used in asthma care. Evidence for asthma mHealth effectiveness is emerging, but systematic assessment is challenging because of technological heterogeneity. To attain more general clinical viability, challenges include advancing the evidence for mHealth effectiveness; promoting accessibility and inclusivity; sustaining patient engagement and successful integration into clinical workflows; ensuring mHealth safety; and considering future regulatory, economic, and pedagogical needs. If these challenges are met, asthma mHealth may help to deliver personalized digital asthma care when combined with novel artificial intelligence approaches, to improve the validity of future asthma research, and to enhance the provision of virtual asthma care. As mobile technology becomes a greater part of our lives and investment and interest in mHealth continues to grow, providers who care for patients with asthma must prepare for this mHealth digital revolution and lobby for safe, effective, and equitable mHealth solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.